Phase 2 Atopic Dermatitis Clinical Trials
37 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–20 of 37 trials
Recruiting
Phase 2
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
Atopic Dermatitis
Apogee Therapeutics, Inc.350 enrolled45 locationsNCT07003425
Recruiting
Phase 2
A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Atopic Dermatitis
Atopic Dermatitis
UCB Biopharma SRL160 enrolled50 locationsNCT07277660
Recruiting
Phase 2
A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis
Atopic Dermatitis (AD)
Bluefin Biomedicine, Inc.225 enrolled55 locationsNCT07105488
Recruiting
Phase 2
A Study of KT-621 Administered Orally to Participants With Moderate to Severe Atopic Dermatitis
Atopic Dermatitis
Kymera Therapeutics, Inc.200 enrolled61 locationsNCT07217015
Recruiting
Phase 2
Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
Atopic Dermatitis (AD)
Enveda Therapeutics60 enrolled17 locationsNCT07298395
Recruiting
Phase 2
A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis
Atopic Dermatitis
Hoffmann-La Roche120 enrolled7 locationsNCT07223697
Recruiting
Phase 2
A Study to Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic Dermatitis
Atopic Dermatitis
Hoffmann-La Roche160 enrolled69 locationsNCT06863961
Recruiting
Phase 2
Phase 2a Study to Assess the Efficacy,Safety and Tolerability of GIA632 in Adult Participants With Moderate to Severe Atopic Dermatitis
Atopic Dermatitis
Novartis Pharmaceuticals84 enrolled28 locationsNCT07220577
Recruiting
Phase 2
A Study to Investigate the Efficacy and Safety of SHR-1905 in Patients With Moderate-to-severe Atopic Dermatitis
Moderate-to-severe Atopic Dermatitis
Guangdong Hengrui Pharmaceutical Co., Ltd75 enrolled1 locationNCT07211542
Recruiting
Phase 2
A Study of SHR-1819 in Patients With Moderate-to-severe Atopic Dermatitis
Moderate-to-severe Atopic Dermatitis
Guangdong Hengrui Pharmaceutical Co., Ltd200 enrolled2 locationsNCT07321951
Recruiting
Phase 2
A Study Evaluating TRIV-509 in Atopic Dermatitis
Atopic Dermatitis
Triveni Bio90 enrolled44 locationsNCT07167758
Recruiting
Phase 2
A Clinical Study to Evaluate SM17 for Atopic Dermatitis
Atopic Dermatitis
SinoMab BioScience Ltd200 enrolled1 locationNCT07445919
Recruiting
Phase 2
A Study to Evaluate Efficacy and Safety of IBI356 in Participants With Moderate to Severe Atopic Dermatitis
Atopic Dermatitis
Innovent Biologics (Suzhou) Co. Ltd.403 enrolled1 locationNCT07330934
Recruiting
Phase 2
Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD
Atopic Dermatitis
Corvus Pharmaceuticals, Inc.200 enrolled1 locationNCT07441395
Recruiting
Phase 2
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
Atopic Dermatitis
Inmagene LLC220 enrolled23 locationsNCT07037901
Recruiting
Phase 2
A Proof-of-Concept Study of IBI3002 in Patients With Moderate to Severe Atopic Dermatitis
Atopic Dermatitis
Innovent Biologics (Suzhou) Co. Ltd.120 enrolled1 locationNCT07399067
Recruiting
Phase 2
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
Atopic Dermatitis
Pfizer340 enrolled97 locationsNCT05995964
Recruiting
Phase 2
A Phase II Clinical Study Evaluating of ZL-82 Tablets in Atopic Dermatitis
Atopic Dermatitis
Chengdu Zenitar Biomedical Technology Co., Ltd111 enrolled1 locationNCT07193589
Recruiting
Phase 2
Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome
Alopecia AreataAtopic Dermatitis
Icahn School of Medicine at Mount Sinai56 enrolled1 locationNCT07242638
Recruiting
Phase 2
Cardamom and Topical Roseomonas in Atopic Dermatitis
Atopic DermatitisEczema
National Institute of Allergy and Infectious Diseases (NIAID)120 enrolled1 locationNCT06096857